Non-interventional Study With Nab-Paclitaxel (Abraxane®)
Non-interventional Study With Nab-Paclitaxel (Abraxane®)
The purpose of this non-interventional study is to collect data on the efficacy and safety of
 Nab-Paclitaxel in the routine application.
The main focus of this non-interventional study is set on answering the following questions:

 -  Can the results observed in controlled clinical trials regarding efficacy and safety be
 reproduced in the routine clinical setting?

 -  Are the side-effects of nab-paclitaxel therapy observed in this study comparable to the
 previously described safety-profile in terms of frequency and intensity?

 -  What are the main reasons for modification or termination of the nab-paclitaxel therapy?

 -  How does nab-paclitaxel therapy influence the patients' quality of life?

 -  What are the criteria for selecting nab-paclitaxel as therapy for metastatic breast
 cancer?
Inclusion Criteria:

 -  Female Patients with metastatic breast cancer, who are at least 18 years old (no upper
 age limit)

 Exclusion Criteria:

 -  Contraindication according to the summary of product characteristics of Abraxane®

 -  No signed patient informed consent form available

 -  pregnant or breastfeeding patients.